One in three men and one in four women in Belgium are diagnosed with cancer before the age of 75. Despite important successes during the last decades, the mechanisms underlying the development and progression of cancer are only partially understood. Hence, cancer researchers are facing great challenges in their quest for better and targeted treatments.

Ghent University (UGent), Ghent University Hospital (UZ Gent) and VIB-UGent (a life sciences research institute in Flanders), have a strong history concerning cancer research. Over the years, different research teams acquired specific expertise that resulted in internationally renowned cancer research. In addition, clinical applications of novel treatments and diagnostic and prognostic tests were implemented. Many research activities and knowhow are however scattered over diverse campuses of UGent, UZ Gent and VIB-UGent.

CRIG's mission is to unite, stimulate and enhance the impact of cancer research at Ghent University, Ghent University Hospital and VIB-UGent.

Peritoneal carcinomatosis arises when cancer cells from other tumors metastasize to the peritoneal cavity and attach to the peritoneum. The primary tumors are often located in the abdomen (stomach cancer, colorectal cancer, liver cancer, ovarian cancer, pancreatic cancer, etc.) but the tumor cells can also reach the peritoneum through the blood of lymphatic system.

More information: https://www.crig.ugent.be/